Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal

Authors: Sujan Neupane, Govinda Prasad Dhungana, Harish Chandra Ghimire

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Adherence to ART is the primary determinant of viral suppression and the risk of transmission, disease progression and death. Adherence of at least 95% is needed for optimal suppression. This study aimed at determining the adherence to Anti-Retroviral Therapy (ART) and its associated factors among People Living with HIV and AIDS in ART Center of Chitwan, Nepal.

Methods

A descriptive cross-sectional study was conducted among 231 clients aged 18 years to 49 years taking ART from Bharatpur Hospital of Chitwan and those who have been enrolled in ART for at least 6 months, were interviewed. Systematic Sampling technique was used. Semi-structured questionnaire was prepared by taking reference from the AIDS Clinical Trial group questionnaire (ACTG). Adherence was measured by patient self report. Data was entered Epi Data 3.1 and analyzed using Statistical Package for Social Sciences (SPSS) software where the P value of < 0.05 was accepted as being statistically significant. The independent variables which were found significant at p-value 0.10 in bivariate analysis were fitted in multivariable logistic regression model. Multivariable logistic regression model was performed to know the net effect of the independent variables on Adherence to ART medication.

Results

The overall adherence in the last month was found to be 87.4%. Wrist watch and mobiles were seen as a facilitating factor for taking ART on time as clients taking ART used to set alarm to get informed of the medication time. Adherence was associated with female sex (AOR = 10.550 CI: 1.854–60.046), family consisting only parents and their children (AOR = 4.877, CI: 1.246–19.079), having no habit of taking alcohol (AOR = 5.842 CI: 1.294–26.383), HIV duration of more than 3 years (AOR = 10.055 CI: 2.383–42.430), picking up ART medications on their own (AOR = 7.861, CI: 1.670–36.998) and not having side effects of ART (AOR = 8.832, CI: 2.059–37.890).

Conclusion

Identifying and evaluating the problems faced by ARV drug users can foster the achievement of ART related goals and addressing ART related problems in a rational way. Effective and appropriate monitoring of non adherence behaviors can help patients increase adherence level fostering improvement in treatment outcome.
Appendix
Available only for authorised users
Literature
2.
go back to reference NCASC. HIV Epidemic Update of Nepal. Kathmandu: NCASC; 2016. NCASC. HIV Epidemic Update of Nepal. Kathmandu: NCASC; 2016.
3.
go back to reference Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13(1):617. Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13(1):617.
4.
go back to reference DOHS. Annual Report. Kathmandu: Ministry of Health; 2016. DOHS. Annual Report. Kathmandu: Ministry of Health; 2016.
5.
go back to reference MOH. National HIV Strategic plan, 2016-2021. Kathmandu: National Centre for AIDS and STD Control; 2016. MOH. National HIV Strategic plan, 2016-2021. Kathmandu: National Centre for AIDS and STD Control; 2016.
6.
go back to reference UNAIDS. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS JC2684. Joint United Nations Programme on HIV/AIDS. 2014 Feb 16. UNAIDS. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS JC2684. Joint United Nations Programme on HIV/AIDS. 2014 Feb 16.
7.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.
9.
go back to reference Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547.CrossRef Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547.CrossRef
10.
go back to reference Shigdel R, Klouman E, Bhandari A, Ahmed LA. Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. HIV/AIDS (Auckl). 2014;6:109. Shigdel R, Klouman E, Bhandari A, Ahmed LA. Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. HIV/AIDS (Auckl). 2014;6:109.
11.
go back to reference Bam K, Rajbhandari RM, Karmacharya DB, Dixit SM. Strengthening adherence to anti retroviral therapy (ART) monitoring and support: operation research to identify barriers and facilitators in Nepal. BMC Health Serv Res. 2015;15(1):188. Bam K, Rajbhandari RM, Karmacharya DB, Dixit SM. Strengthening adherence to anti retroviral therapy (ART) monitoring and support: operation research to identify barriers and facilitators in Nepal. BMC Health Serv Res. 2015;15(1):188.
12.
go back to reference Oku A, Owoaje E, Oku O, Monjok E. Prevalence and determinants of adherence to highly active antiretroviral therapy (HAART) amongst a cohort of HIV positive women accessing treatment in a tertiary health Facility in Southern Nigeria. J HIV AIDS Infect Dis. 2013;1:1–8. Oku A, Owoaje E, Oku O, Monjok E. Prevalence and determinants of adherence to highly active antiretroviral therapy (HAART) amongst a cohort of HIV positive women accessing treatment in a tertiary health Facility in Southern Nigeria. J HIV AIDS Infect Dis. 2013;1:1–8.
13.
go back to reference Bam K. Adherence to anti-retroviral therapy among people living with HIV and AIDS in far west, Nepal; 2009. Bam K. Adherence to anti-retroviral therapy among people living with HIV and AIDS in far west, Nepal; 2009.
14.
go back to reference Karki J, Shakya S. Problems faced by antiretroviral (ARV) drug users in Kathmandu. J Nepal Health Res Counc. 2016;14(32):27–32. Karki J, Shakya S. Problems faced by antiretroviral (ARV) drug users in Kathmandu. J Nepal Health Res Counc. 2016;14(32):27–32.
15.
go back to reference Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. New York: Wiley; 2013. Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. New York: Wiley; 2013.
16.
go back to reference Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. N Am J Med Sci. 2013;5(3):220. Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. N Am J Med Sci. 2013;5(3):220.
17.
go back to reference Yadeta AD, Chaka EE. Predictors of Art Adherence among People Living with Human Immune Virus Attending Treatment at Hospitals in West Shewa Zone, Oromia Region, Ethiopia, 2015. J Health Med Nursing. 2016;29. Yadeta AD, Chaka EE. Predictors of Art Adherence among People Living with Human Immune Virus Attending Treatment at Hospitals in West Shewa Zone, Oromia Region, Ethiopia, 2015. J Health Med Nursing. 2016;29.
Metadata
Title
Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal
Authors
Sujan Neupane
Govinda Prasad Dhungana
Harish Chandra Ghimire
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7051-3

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue